CoChat

Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices

Moench, Thomas R., Chipato, Tsungai, Padian, Nancy S. · 2001 · AIDS
Cited by 147

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Introduction The need for woman-controlled barrier contraceptives that protect against both bacterial and viral sexually transmitted pathogens is widely recognized [1–7]. In the absence of an effective vaccine or treatment, contraceptive methods capable of preventing sexual transmission of HIV as well as other sexually transmitted diseases (STD) are vital for protecting the health of women. Moreover, widespread violence against women, double standards of sexual behavior, and the imbalance of power in many sexual partnerships make methods initiated and controlled by women critically important. These issues may severely limit existing options for protection among women who cannot negotiate sex with their male partners without being accused of cheating, of being ‘loose’ women, or of accusing their partners of infidelity [3,4]. Vaginal microbicides (topical chemical barriers that protect against acquisition of a variety of STD pathogens, including HIV) may provide such alternative woman-controlled methods. Compared to male and female condoms, microbicides are expected to interfere less with intimacy and sexual pleasure, and be more discrete. Because detergents like nonoxynol-9 (N9) are microbicidal as well as spermicidal, several existing N9 contraceptives have been tested in observational and controlled trials as microbicides for HIV/STD prevention [8–17]. Modest protection against Chlamydia and gonorrhea has been shown [8–12], but HIV prevention studies [12–17] have yielded mixed results and overall, the protective effect for HIV appears doubtful. In fact, the most recently completed trial [17] reported greater HIV transmission in the women using N9 compared to those using a placebo gel, possibly due to detergent-induced compromise of the epithelial barrier after intensive use. New microbicides (only some of which are spermicidal) are being developed for vaginal protection, in an effort to improve efficacy, safety, and acceptability compared to existing detergent-based products such as N9. Although many of these new microbicides show robust activity against HIV and other STD pathogens, and some also appear to be less toxic than N9, achieving reliable protection with microbicides remains a significant challenge. We contend that the likelihood of success of such products could be greatly increased by an alternative prevention approach, namely the combination of a microbicide and an internal barrier device that protects the cervix. Like condoms, these devices (diaphragms, caps, and other novel designs) create a physical barrier that covers the cervix. Yet because they are worn completely inside the vagina, they avoid the obtrusiveness that limits the acceptability of male and female condoms. With microbicide applied on both the cervical and vaginal sides of these devices (as is commonly recommended for contraception in the UK, but not in the USA or other countries), they should offer all the benefits of the microbicide, with additional benefits provided by physical protection of the cervix. Although internal barrier devices cover the cervix, they do not provide a barrier for most of the vaginal epithelium. Thus, if transmission susceptibility were distributed equally across all epithelial surfaces, internal barrier devices might add only modestly to the protection given by the microbicides with which they were used. However, substantial epidemiological and biological evidence suggests that susceptibility is not evenly distributed, but that the cervix is a site of particularly high susceptibility to HIV and STD transmission. Thus, internal barrier devices that cover the cervix may enhance significantly the protection against HIV and STD that may be provided by microbicides alone. In addition, applying the microbicide to the vaginal side of the barrier may confer vaginal protection as well. Currently the traditional diaphragm and cervical cap are the only tested and approved internal devices that provide physical protection of the cervix. However, several new barrier methods are under development or at various stages of testing. These method include the Leah's shield (similar to a loose fitting cervical cap made of rubber with a loop for easy removal), the Femcap (also similar to the cervical cap but with a brim designed to fit into the vaginal fornices), the SILCS diaphragm [a new single-size design (SILCS Inc., Tinton Falls, New Jersey, USA) expected to be easier to insert and remove], and disposable diaphragms (some of which may be provided with microbicide preapplied). Evidence for the importance of the cervix in acquisition of STD and HIV Cervical infection with bacterial STD STD facilitate transmission of HIV both by increasing susceptibility among the uninfected, and by increasing the infectiousness among those infected with HIV [18]. Thus, the role of the cervix in STD susceptibility, and the importance of cervical protection in blocking acquisition of STD, are both relevant to preventing transmission of H

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00002030-200109070-00001

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 147

Metadata

Authors
Moench, T. R., Chipato, T., & Padian, N. S.
Venue
AIDS
Published
2001-09
Volume
15
Issue
13
Pages
1595-1602
ISSN
0269-9370 (ISSN-L)
OpenAlex
W2026152916
Cited by
147
References
2
FWCI
4.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. https://app.cochat.ai/papers/10.1097/00002030-200109070-00001
The paper
Moench, T. R., Chipato, T., & Padian, N. S. (2001). Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS. https://doi.org/10.1097/00002030-200109070-00001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.